Newly Diagnosed Multiple Myeloma Terminated Phase 2 Trials for Lenalidomide (DB00480)

Also known as: Newly Diagnosed Multiple Myeloma (NDMM) / Newly Diagnosed, Multiple Myeloma / Multiple Myeloma, Newly Diagnosed

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03733691Ph 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for MM PatientsTreatment